Adaptive Biotechnologies to present at two major investor conferences in late May and early June

Adaptive Biotechnologies, a biotech company focused on immune system genetics, announced participation in two upcoming investor conferences: the Craig-Hallum Annual Institutional Investor Conference on May 28 and the William Blair Growth Stock Conference on June 3. The company will hold one-on-one meetings and deliver a presentation, accessible via webcast on their website. These events provide a platform to update investors on their progress in developing immune-driven clinical products for diseases like cancer and autoimmune disorders.